Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 21790528)

1.

Array-based DNA methylation profiling in acute myeloid leukaemia.

Wilop S, Fernandez AF, Jost E, Herman JG, Brümmendorf TH, Esteller M, Galm O.

Br J Haematol. 2011 Oct;155(1):65-72. doi: 10.1111/j.1365-2141.2011.08801.x. Epub 2011 Jul 26.

PMID:
21790528
2.

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.

Galm O, Wilop S, Lüders C, Jost E, Gehbauer G, Herman JG, Osieka R.

Ann Hematol. 2005 Dec;84 Suppl 1:39-46.

PMID:
16231140
3.

Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.

Kroeger H, Jelinek J, Estécio MR, He R, Kondo K, Chung W, Zhang L, Shen L, Kantarjian HM, Bueso-Ramos CE, Issa JP.

Blood. 2008 Aug 15;112(4):1366-73. doi: 10.1182/blood-2007-11-126227. Epub 2008 Jun 3.

4.

Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.

Griffiths EA, Gore SD, Hooker C, McDevitt MA, Karp JE, Smith BD, Mohammad HP, Ye Y, Herman JG, Carraway HE.

Leuk Lymphoma. 2010 Sep;51(9):1711-9. doi: 10.3109/10428194.2010.496505.

5.

Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.

Lenz G, Hutter G, Hiddemann W, Dreyling M.

Ann Hematol. 2004 Oct;83(10):628-33. Epub 2004 Aug 12.

PMID:
15309527
6.

Quantitative DNA methylation predicts survival in adult acute myeloid leukemia.

Bullinger L, Ehrich M, Döhner K, Schlenk RF, Döhner H, Nelson MR, van den Boom D.

Blood. 2010 Jan 21;115(3):636-42. doi: 10.1182/blood-2009-03-211003. Epub 2009 Nov 10.

7.

Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.

Jost E, Schmid J, Wilop S, Schubert C, Suzuki H, Herman JG, Osieka R, Galm O.

Br J Haematol. 2008 Sep;142(5):745-53. doi: 10.1111/j.1365-2141.2008.07242.x. Epub 2008 Jun 3.

PMID:
18537968
8.

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.

Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP.

Blood. 2009 Feb 5;113(6):1315-25. doi: 10.1182/blood-2008-06-163246. Epub 2008 Oct 2.

9.
10.

[Detection of p16 gene methylation status in adult patients with acute leukemia by using n-MSP].

Fan LP, Shen JZ, Ye BG, Lin FA, Fu HY, Zhou HR, Shen SF, Yu AF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Apr;15(2):258-61. Chinese.

PMID:
17493327
11.

Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats.

Saied MH, Marzec J, Khalid S, Smith P, Down TA, Rakyan VK, Molloy G, Raghavan M, Debernardi S, Young BD.

PLoS One. 2012;7(3):e33213. doi: 10.1371/journal.pone.0033213. Epub 2012 Mar 29.

12.

Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.

Morenos L, Chatterton Z, Ng JL, Halemba MS, Parkinson-Bates M, Mechinaud F, Elwood N, Saffery R, Wong NC.

Mol Cancer. 2014 May 24;13:123. doi: 10.1186/1476-4598-13-123.

13.

Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.

Szankasi P, Ho AK, Bahler DW, Efimova O, Kelley TW.

Leuk Res. 2011 Feb;35(2):200-7. doi: 10.1016/j.leukres.2010.09.018. Epub 2010 Oct 20.

PMID:
20970189
14.

Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.

Hess CJ, Ameziane N, Schuurhuis GJ, Errami A, Denkers F, Kaspers GJ, Cloos J, Joenje H, Reinhardt D, Ossenkoppele GJ, Zwaan CM, Waisfisz Q.

Cell Oncol. 2008;30(4):299-306.

PMID:
18607065
15.

Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.

Zheng S, Ma X, Zhang L, Gunn L, Smith MT, Wiemels JL, Leung K, Buffler PA, Wiencke JK.

Cancer Res. 2004 Mar 15;64(6):2000-6.

16.

Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.

Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M.

Cancer Res. 2006 Jun 15;66(12):6118-28.

17.

Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation.

Tao YF, Xu LX, Lu J, Cao L, Li ZH, Hu SY, Wang NN, Du XJ, Sun LC, Zhao WL, Xiao PF, Fang F, Li YH, Li G, Zhao H, Li YP, Xu YY, Ni J, Wang J, Feng X, Pan J.

J Transl Med. 2014 Jun 25;12:182. doi: 10.1186/1479-5876-12-182.

18.

Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.

Suzuki R, Onizuka M, Kojima M, Shimada M, Fukagawa S, Tsuboi K, Kobayashi H, Shintani A, Ogawa Y, Kawada H, Hotta T, Ando K.

Br J Haematol. 2007 Sep;138(5):624-31.

PMID:
17686056
19.

Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.

Akalin A, Garrett-Bakelman FE, Kormaksson M, Busuttil J, Zhang L, Khrebtukova I, Milne TA, Huang Y, Biswas D, Hess JL, Allis CD, Roeder RG, Valk PJ, Löwenberg B, Delwel R, Fernandez HF, Paietta E, Tallman MS, Schroth GP, Mason CE, Melnick A, Figueroa ME.

PLoS Genet. 2012;8(6):e1002781. doi: 10.1371/journal.pgen.1002781. Epub 2012 Jun 21.

20.

DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.

Garcia-Manero G, Daniel J, Smith TL, Kornblau SM, Lee MS, Kantarjian HM, Issa JP.

Clin Cancer Res. 2002 Jul;8(7):2217-24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk